News

Jim Cramer recently gave Eli Lilly a thumbs-up, noting it’s a great time to buy because the stock has dropped significantly.
Jim Cramer continues his enthusiastic endorsement of Broadcom, calling it a top position in his Charitable Trust. He ...
In a Tuesday interview with CNBC's Jim Cramer, Okta CEO Todd McKinnon described cybersecurity challenges that are coming up ...
We recently published a list of Jim Cramer Had These 21 Stocks on His Radar. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other stocks that Jim ...
Lending support to his choice, Rocket Companies, on May 8, posted better-than-expected quarterly sales. Markets expect rate ...
CNBC’s Jim Cramer on Friday detailed how President Donald Trump’s global trade decisions seriously inhibit two of the U.S.’s biggest tech titans.
Eli Lilly, Navitas, Red Cat, Mr. Cooper, Rocket, Liberty Energy, Rio Tinto, and DeFi Development. Russia Calls Trump ...
CNBC's Jim Cramer on Friday guided investors through next week on Wall Street, saying quarterly reports from Nvidia, Costco, Dell and Salesforce have the potential to move their respective sectors and ...
Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...
Cigna’s Evernorth has introduced a new pharmacy benefit that caps out-of-pocket costs for GLP-1 weight loss medications at $200 per month, in a move analysts say is more favorable for Eli Lilly ...